Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

First-in-Human Clinical Translation of a Near-Infrared, Nerve-Specific Fluorophore to Facilitate Tissue-Specific Fluorescence-Guided Surgery

Award Number: R01NS116994
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/15/2020
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

First-in-Human Clinical Translation of a Near-Infrared, Nerve-Specific Fluorophore to Facilitate Tissue-Specific Fluorescence-Guided Surgery - PROJECT SUMMARY Safe and effective surgery accomplishes the required intervention, leaving the patient with the minimum necessary morbidity. To accomplish this goal, surgeons must distinguish between tissue types, preserving those of high value. Peripheral nerves are critically important for life-sustaining functions. When severed, peripheral nerves heal poorly and rarely recover full function. Iatrogenic nerve injury can have long-term, catastrophic consequences for the patient. Standard white-light visualization is often adequate to guide surgery in normal anatomy, however, in the setting of trauma, tumors, prior surgery, congenital anomalies, and radiation therapy, critical nerves may be difficult to recognize. Additionally, positive identification of nerve tissue during minimally invasive surgery can be challenging due to the reliance on anatomical landmarks that are inconsistent across patients. Fluorescence-guided surgery (FGS) is a nascent form of surgical navigation that seeks to increase the safety and efficacy of surgery through enhanced recognition of important anatomical structures using tissue- and disease-specific fluorophores. To date, research in FGS has focused primarily on the identification of cancers; comparatively little effort has been applied to the identification of normal structures. Because of their critical importance to function and limited healing capacity, successful translation of a nerve-specific fluorophore to provide visual identification of nerves would lead to a rapid, global shift in surgical methods and a reduction in morbidity from iatrogenic nerve injuries. Our research group has cooperatively developed a new, near-infrared (NIR) fluorescent contrast agent (IT01-08) that binds to nerve tissue with high specificity in rodent and swine models and is compatible with existing clinical FGS systems. In the proposed studies, we will advance IT01-08 toward human use by scaling its synthesis and formulation using good manufacturing practice (GMP) compliant methods and completing good laboratory practice (GLP) compliant pre-clinical testing that will enable us to successfully apply for IND approval to initiate a Phase I, first-in-human study of IT01-08. Our group has a strong history of early human trialing of novel fluorophores for FGS. We will further enhance our ability to analyze the performance of IT01-08 by performing this study in patients undergoing lower extremity amputation, whereby we will be able to excise patient nerve tissue and evaluate it histologically for toxicity. Our primary study endpoints will be surgical signal detection and nerve signal-to-background tissue ratio (SBR) >2. This study will deliver: synthesis of GMP-grade formulated, lyophilized, sterile IT01-08 for systemic administration, GLP-compliant preclinical toxicology testing of formulated IT01-08, and Phase I data that will position our team to move to Phase II trialing of IT01-08. This work will result in an expedient pathway to clinical translation of a fluorescent reporter that will be revolutionary in its ability to reduce iatrogenic nerve injury.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	DARTMOUTH-HITCHCOCK CLINIC	1 MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	5	2/26/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $402,132 )
2025	2025	DARTMOUTH-HITCHCOCK CLINIC	1 MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	5	5/6/2025	NON-COMPETING CONTINUATION	$402,132
														Subtotal = $402,132

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	DARTMOUTH-HITCHCOCK CLINIC	1 MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	4	8/28/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $548,262 )
2023	2023	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	4	8/4/2023	SUPPLEMENT FOR EXPANSION	$146,100
2023	2023	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	4	4/21/2023	NON-COMPETING CONTINUATION	$402,162
														Subtotal = $548,262

Issue Date FY: 2022 ( Subtotal = $589,567 )
2022	2022	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	5/27/2022	NON-COMPETING CONTINUATION	$589,567
														Subtotal = $589,567

Issue Date FY: 2021 ( Subtotal = $607,951 )
2021	2021	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	5/18/2021	NON-COMPETING CONTINUATION	$607,951
														Subtotal = $607,951

Issue Date FY: 2020 ( Subtotal = $620,782 )
2020	2020	DARTMOUTH-HITCHCOCK CLINIC	ONE MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	5/14/2020	NEW	$620,782
														Subtotal = $620,782

Grand Total All Awards = $2,768,694

Top

All Categories

About

Search

Reports

Data Submission

Award Information

First-in-Human Clinical Translation of a Near-Infrared, Nerve-Specific Fluorophore to Facilitate Tissue-Specific Fluorescence-Guided Surgery

Award Number: R01NS116994

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/15/2020

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer